The global single-use bioreactors market reached a value of US$ 2.54 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 6.23 Billion by 2027, exhibiting a CAGR of 15.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A single-use bioreactor (SUB), also known as a disposable bioreactor, relies on a disposable bag instead of a culture vessel made using stainless steel or glass. It is flexible and easy to use and install, and requires fewer utility requirements, including steam and water. Besides this, it reduces labor costs, minimizes the risk of cross-contamination, and eliminates the cleaning process and validation issue. As a result, it finds extensive applications in contract research organizations (CROs) and contract manufacturing organizations (CMOs) worldwide. Single-Use Bioreactors Market Trends: SUBs are employed in the pharmaceutical industry for media and buffer preparation, cell harvesting, filtration, purification, and virus inactivation. They are also used in academic and commercial-scale laboratories for drug discovery, biofuel manufacturing, and the development of vaccines and antibodies. This, in confluence with the burgeoning biopharmaceutical industry, represents one of the key factors impelling the growth of the market. Moreover, autoclaving a conventional bioreactor can become a lengthy, costly, and inconsistent pharmaceutical manufacturing process. However, SUBs utilize presterilized bioprocess bags and consequently reduce the additional costs and time of sterilization. Besides this, as they have fewer moving parts than conventional bioreactors, SUBs are less expensive to maintain. Apart from this, SUBs have a lower overall impact on the environment compared to stainless steel equipment. This, coupled with the growing number of clinical trials around the world, is catalyzing their demand across the globe. Furthermore, leading players are increasingly focusing on product innovations and mergers and acquisitions (M&A) to expand their customer base and increase their geographical presence. This, along with the rising adoption of single-use technology (SUT), is augmenting the overall sales and profitability.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global single-use bioreactors market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, type, cell type, molecule type and end user.
Breakup by Product Type: Single-use Bioreactor Systems Media Bags Filtration Assemblies Others
Breakup by Type: Stirred-tank Bioreactors Wave-induced Bioreactors Bubble-column Bioreactors Others
Breakup by Cell Type: Mammalian Cell Bacteria Yeast Others
Breakup by End User: Pharmaceutical and Biopharmaceutical Companies Contract Research Organizations Academic and Research Institutes Others
Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report: How has the global single-use bioreactors market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global single-use bioreactor market? What are the key regional markets? What is the breakup of the market based on the product type? What is the breakup of the market based on the type? What is the breakup of the market based on the cell type? What is the breakup of the market based on the molecule type? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global single-use bioreactor market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
Report Scope: This report identifies the global preclinical research outsourcing services market, along with all major global preclinical CRO companies.The total preclinical research outsourcing services market is segmented globally and by geographic regions. The service areas provided by preclinical CROs are extensively...
Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Drugs In Development, 2022, provides an overview of the Genital Herpes (Infectious Disease) pipeline...
Bioanalytical testing involves analytical methods used for the detailed examination of biological and biotechnology products.Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services...
Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Female Hypoactive Sexual Desire Disorder - Drugs In Development, 2022, provides an overview...
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2015-2022 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The report provides a detailed understanding and analysis of how and why companies enter business, product,...
Degenerative Disc Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players,...
Toll Like Receptor 8 (CD288 or TLR8) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Toll Like Receptor 8 - Drugs In Development, 2022’; Toll Like Receptor 8 (CD288 or TLR8) pipeline...
KEY FINDINGS The global immunoglobulin market is anticipated to rise with a CAGR of 6.87% across the forecast years of 2022 to 2030. The market’s growth is strengthened by the increasing incidence of autoimmune disorders as well as immunodeficiency diseases, the rise in the geriatric populace, and the growing research and...
The global bioreactor market reached a value of US$ 5.64 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 11.84 Billion by 2027, exhibiting a CAGR of 12.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
The Global Biosimilars Partnering Terms and Agreements 2010 to 2022 report provides an understanding and access to the Biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Biosimilars partnering deals Disclosed headlines, upfronts, milestones and royalties...
Pharmaceutical
Biopharmaceutical
Healthcare
Research And Development
World
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.